RECENT NEWS

Harley Street clinics showcase London’s medical excellence at Arab Health

Long-term owner and guardian of the Harley Street Medical Area (HSMA), The Howard de Walden Estate is returning to Arab Health for the sixth year, bringing with it 12 of the HSMA’s world leading clinics and hospital groups.

Nurse leader recognised in King's Honours List for services to nursing

Carol Kefford, former Clinical Director and Chief Nurse at Nuffield Health, and current Chief Nursing Executive at HCA Healthcare UK, has been awarded an OBE for services to nursing in The King’s New Year Honours List 2023.

Enzyme that protects against viruses could fuel cancer evolution

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells, according to a study led by investigators at Weill Cornell Medicine. The finding suggests that the enzyme may be a potential target for future cancer treatments.

UK cements 10-year-partnership with Moderna

Moderna is to invest in mRNA research and development (R&D) in the UK, and build a state-of-the-art vaccine manufacturing centre.

AI improves colorectal cancer screening in Lynch syndrome

People with Lynch syndrome have a higher hereditary risk of colon cancer. Despite regular endoscopic surveillance, it remains elevated in those affected. Researchers at the National Center for Hereditary Tumor Diseases (NZET) at Bonn University Hospital (UKB) have now found that artificial intelligence (AI) can improve the effectiveness of colonoscopy in the presence of Lynch syndrome. The study results have been published online in the United European Gastroenterology Journal.

Support for nurses facing financial hardship

Florence, the healthcare platform using technology to help tackle the shortage of healthcare staff globally, has partnered with the Healthcare Workers' Foundation to support the charity in its mission to provide additional hardship grants to workers suffering exceptional financial hardship.

Potentially deadly infection has dangerous ally lurking in our guts

New research from the University of Virginia School of Medicine and collaborators reveals how microorganisms found in our guts can worsen dangerous C. difficile infections. The discovery could help doctors identify patients at risk for severe illness and open the door to new treatments.

BMA survey highlights state of junior doctors' finances and morale

Junior doctors are cutting back on buying food and heating their homes, as they regularly borrow money from family and friends to help make ends meet.

Warning signs of sudden cardiac arrest provide opportunity for prevention

Primary care visits rise sharply in the weeks immediately preceding a sudden cardiac arrest, according to results from the ESCAPE-NET project. The project is backed by the European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) and the European Resuscitation Council (ERC).

AI better than human eye at predicting brain metastasis outcomes

A recent study by York University researchers suggests an innovative artificial intelligence (AI) technique they developed is considerably more effective than the human eye when it comes to predicting therapy outcomes in patients with brain metastases.

Common food dye can trigger inflammatory bowel diseases

Long-term consumption of Allura Red food dye can be a potential trigger of inflammatory bowel diseases (IBDs), Crohn’s disease and ulcerative colitis, according to a new study.

Works completed to facilitate £1m elective care hub

Dudleys Consulting Engineers has completed works to facilitate the installation of a new £1 million elective care hub at Wharfedale Hospital in Otley. Two new temporary theatres have been installed on site by Leeds Teaching Hospitals NHS Trust to tackle the backlog of patients waiting for treatment.

Novel device monitors breath sounds to predict respiratory failure in ICU patients after extubation

Researchers developed a novel device that detects abnormal breathing sounds to predict whether an ICU patient is likely to suffer from respiratory complications after removal from a mechanical ventilator, alerting intensive care teams to the need for emergency interventions at an early phase after extubation.

Metformin use significantly reduces risk of joint replacement in people with type 2 diabetes

A team of researchers from China, Taiwan and Australia aimed to determine whether metformin use was associated with a lower risk of total knee replacement (TKR) or total hip replacement (THR), as evidence to date has been sparse and inconclusive.

Over £175 million for cutting-edge genomics research

Patients with cancer and children born with treatable rare genetic diseases are set to benefit from earlier diagnosis and faster access to treatment, following a £175 million boost to cutting-edge genomics research announced by the Health and Social Care Secretary.

AI project aimed at detecting early-stage lung cancer

Clinithink has partnered with AstraZeneca Oncology UK in a new project that aims to find patients with lung cancer at an early stage where treatment can be more effective.

MEDICA 2022: Success for HealthTech innovators looking to strengthen trade ties

MEDICA 2022 has once again proven its prominence as a top-drawer trade event for UK life science innovators who are export-ready and looking to grow.

Vitamin D deficiency leads to dementia

Dementia is one of the major causes of disability and dependency among older people worldwide. However, the latest research suggests that there may be a link to Vitamin D deficiency.

Update on MHRA review into safe use of valproate

Valproate is approved in the UK to treat epilepsy and bipolar disorder. Because of the known risk of birth defects and neurodevelopmental disorders following use of valproate in pregnancy, valproate should only be used in women of child-bearing potential if a Pregnancy Prevention Programme is in place, which includes a requirement to use effective contraception.

New biomarker could guide treatment for lupus patients

Levels of a particular antibody in the blood could predict how well people with lupus respond to a new treatment approach, according to UCLH and UCL research.

Latest Issues

AfPP Plymouth Regional Conference

TBC, Plymouth
10th May 2025

Theatres and Decontamination Conference

CBS Arena
20th May 2025

BAUN Day Educational Event

Hilton, Belfast
6th June 2025

EBME Expo 2025

Coventry Building Society Arena, UK
25th - 26th June 2025